What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
His primary areas of investigation include Psychiatry, Depression, Internal medicine, Clinical psychology and Cognition.
The concepts of his Psychiatry study are interwoven with issues in Alzheimer's disease, Randomized controlled trial, Dementia and Rating scale.
His Late life depression and Major depressive disorder study in the realm of Depression interacts with subjects such as Suicidal ideation.
Benoit H. Mulsant combines subjects such as Nortriptyline, Endocrinology and Major depressive episode with his study of Internal medicine.
As a part of the same scientific study, Benoit H. Mulsant usually deals with the Clinical psychology, concentrating on MEDLINE and frequently concerns with Positive and Negative Syndrome Scale.
His Cognition research integrates issues from Developmental psychology, Bipolar disorder and Activities of daily living.
His most cited work include:
- Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale (1435 citations)
- Reducing Suicidal Ideation and Depressive Symptoms in Depressed Older Primary Care Patients: A Randomized Controlled Trial (828 citations)
- Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. (499 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Psychiatry, Depression, Internal medicine, Clinical psychology and Cognition.
His Psychiatry research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Dementia.
His work in the fields of Depression, such as Late life depression, Antidepressant and Paroxetine, intersects with other areas such as Suicidal ideation.
His studies deal with areas such as Endocrinology, Oncology, Venlafaxine, Olanzapine and Risperidone as well as Internal medicine.
His Clinical psychology study which covers Bipolar disorder that intersects with Mood.
His Cognition study deals with Schizophrenia intersecting with Neuroscience and Dopamine receptor D2.
He most often published in these fields:
- Psychiatry (63.28%)
- Depression (43.39%)
- Internal medicine (34.80%)
What were the highlights of his more recent work (between 2018-2021)?
- Depression (43.39%)
- Major depressive disorder (22.15%)
- Internal medicine (34.80%)
In recent papers he was focusing on the following fields of study:
Benoit H. Mulsant mostly deals with Depression, Major depressive disorder, Internal medicine, Randomized controlled trial and Cognition.
His Depression research is multidisciplinary, incorporating elements of Pharmacotherapy, Clinical psychology and Anxiety.
His Major depressive disorder study is concerned with Psychiatry in general.
His research on Psychiatry often connects related topics like Public health.
His Randomized controlled trial research focuses on Psychotic depression and how it connects with Sertraline and Quality of life.
His study explores the link between Cognition and topics such as Physical therapy that cross with problems in Transcranial direct-current stimulation.
Between 2018 and 2021, his most popular works were:
- Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias (124 citations)
- Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias (124 citations)
- The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders. (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Disease
His main research concerns Pandemic, Psychiatry, Dementia, Randomized controlled trial and Depression.
In Psychiatry, he works on issues like Public health, which are connected to Mental health.
His Dementia research incorporates elements of Psychosocial, Pediatrics, Cognitive remediation therapy and MEDLINE.
His study with Randomized controlled trial involves better knowledge in Internal medicine.
His Depression research incorporates themes from Polypharmacy, Clinical psychology and Anxiety.
The study incorporates disciplines such as Recall, Cognition, Electroconvulsive therapy and Mood disorders in addition to Major depressive disorder.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
